Centre fast tracks emergency approvals for foreign Covid-19 vaccines to augment India’s vaccination coverage, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The decision came after the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) recommended that vaccines for Covid-19, which have been developed, are being manufactured in foreign countries and which have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO (Emergency Use Listing) may be granted emergency use approval in India., The decision came after the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) recommended that vaccines for Covid-19, which have been developed, are being manufactured in foreign countries and which have been granted emergency approval for restricted use by USFDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO (Emergency Use Listing) may be granted emergency use approval in India., , Read More